Strong Overall Financials and Same-Store NOI
Q4 FFO as adjusted $0.47 per share and AFFO $0.40 per share; full-year FFO as adjusted $1.84 and AFFO $1.69. Total portfolio same-store cash NOI growth of 3.9% in Q4 and 4.0% for the full year 2025.
Outpatient Medical Outperformance and Record Leasing
Outpatient delivered sector-leading results: executed 4.9 million sq ft of leasing in 2025 (including a company-record 1.0 million sq ft of new leasing), cash releasing spreads of 5% on renewals, 79% tenant retention, 91% year-end occupancy and same-store NOI growth of 3.9% (above guidance).
Value-Accretive Outpatient Dispositions and Synergies
Selling fully stabilized, less-core outpatient assets at attractive prices including $325 million in Q4 at ~6% cap rate; merger with Physicians Realty Trust generated ~$70 million of synergies supporting earnings.
Senior Housing — Strong Growth and Strategic IPO Plan
Senior housing: full-year same-store NOI growth 12.6% and Q4 growth 16.7% (management also referenced 17% in Q4). Announced plan to contribute entire senior housing portfolio to planned Janus Living IPO (Healthpeak to manage and remain a meaningful shareholder). Closed JV partner buyout for $314 million (46.5% interest) and expect to contribute additional $360 million of acquisitions to Janus Living pipeline.
Lab Portfolio: Signs of Leasing Momentum and Improving Capital Markets
Life science leasing activity in 2025 included nearly 1.5 million sq ft executed (562k sq ft of new leasing) and positive 5% cash releasing spreads on renewals. Management reported improving capital raising and M&A since Labor Day 2025, an active pipeline (~1.5 million sq ft) and an additional ~100k sq ft of leasing activity under LOI since year-end.
Balance Sheet Liquidity and Active M&A/Capital Recycling
Net debt to adjusted EBITDA ~5.2x with $2.4 billion liquidity. YTD 2026 completions of $464 million of acquisitions (incl. $314 million JV buyout and Gateway acquisition). Management plans $1B+ of asset sales/recaps/loan repayments in 2026 and has $1.1B of refinancing activity scheduled.
Disciplined 2026 Guidance with Clear Segment Assumptions
2026 FFO as adjusted guidance of $1.70–$1.74; total same-store NOI guide -1% to +1% with outpatient +2% to +3%, lab -5% to -10%, and senior housing +8% to +12% — management articulated drivers and timing for each segment.
Experienced Leadership and Talent Additions
Strategic hires to strengthen platforms and markets: Dennis Sullivan (San Diego), Claire Brown (Boston), Jonathan Hughes (SVP finance & IR for Janus Living effort) and Omkar Joshi (head of enterprise innovation).